Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$727K Sell
3,016
-34
-1% -$7.5K 0.36% 60
2019
Q3
$590K Sell
3,050
-362
-11% -$69.5K 0.31% 62
2019
Q2
$629K Buy
3,412
+153
+5% +$27.4K 0.3% 62
2019
Q1
$619K Sell
3,259
-874
-21% -$167K 0.32% 60
2018
Q4
$805K Buy
4,133
+2,174
+111% +$424K 0.45% 55
2018
Q3
$406K Buy
+1,959
New +$386K 0.23% 70

Other funds holding AMGN

Lau Associates's AMGN Position: Q4 2019 in Review

Lau Associates reduced its Amgen (AMGN) stake by 1.1% in Q4 2019, selling an estimated $7.5K and leaving 3,016 shares worth $727K. The position accounts for 0.36% of the portfolio, ranked #60.

Lau Associates first reported a position in AMGN in Q3 2018 and has held it in 6 quarters since. The position peaked at $805K in Q4 2018. 2,107 funds tracked by Wall St. Rank hold AMGN as of Q4 2019.

  • Lau Associates held 3,016 shares of Amgen worth $727K as of Q4 2019.
  • Lau Associates sold 34 Amgen shares in Q4 2019, an estimated $7.5K.
  • Amgen made up 0.36% of Lau Associates's portfolio in Q4 2019, its #60 holding.
  • Lau Associates first reported a position in Amgen in Q3 2018 and has held it in 6 quarters since.
  • Lau Associates's Amgen position peaked at $805K in Q4 2018.
  • 2,107 funds tracked by Wall St. Rank held Amgen as of Q4 2019.

Based on Lau Associates's 13F filing for Q4 2019, filed 5 Feb 2020.